Prices may vary in areas outside metABCD ropolitan Washington. ESU V1 V2 V3 V4 Democracy Dies in Darkness thursday, november 21, 2024 . Shower, windy 53/37 • Tomorrow: Cloudy, chilly 46/40 B6 $3 Trump's picks draw from Project 2025 RFK Jr.'s skepticism, Oregon vote further turn tide against fluoride Man guilty in murder that became a GOP focus Killing of Laken Riley in Georgia helped fuel debate on immigration BY KIM BELLWARE a Georgia judge sentenced Jose antonio Ibarra to life in prison without the possib ...

Viatris Inc. (NASDAQ:VTRS) Jefferies London Healthcare Conference Transcript November 21, 2024 5:30 AM ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Corinne Le Goff - Chief Commercial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo All right. Good morning, everybody. Thanks. Why don’t we get started? For those of you who don’t know me, I’m Glen Santangelo. I’m the analyst at Jefferi ...

CRISPR Therapeutics AG (NASDAQ:CRSP) Jefferies London Healthcare Conference November 20, 2024 11:00 AM ET Company Participants Samarth Kulkarni - Chief Executive Officer and Chairman Conference Call Participants Maury Raycroft - Jefferies Maury Raycroft Hi, everyone. My name is Maury Raycroft, I'm one of the biotech analysts at Jeffreys. I'd like to welcome Sam Kulkarni, the CEO of CRISPR Therapeutics. Sam, thanks so much for joining us today. Samarth Kulkarni Thank you for having me. Maury Raycroft And we' ...

Affirm Holdings, Inc. (NASDAQ:AFRM) FT Partners FinTech Conference November 20, 2024 4:00 PM ET Company Participants Wayne Pommen - Chief Revenue Officer Conference Call Participants Unidentified Company Representative All right. Thank you, everybody. We are very excited to be capping-off our inaugural FinTech Conference here today with Wayne Pommen, the Chief Revenue Officer of Affirm. So Wayne, thanks so much for joining. Partially excited to have you here as not a CEO or CFO, which seems to be the overwh ...

Zoetis Inc. (NYSE:ZTS) Jefferies London Healthcare Conference November 20, 2024 10:00 AM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo Thank you for taking the time to join us this afternoon. We're very excited to have Zoetis for our next presentation. For those of you who don't know me, I'm Glen Santangelo. I'm the analyst at Jefferies that covers the stock. I cover a number of things in addition to animal health, spec pharma and HCIT. ...

General Motors Company (NYSE:GM) Barclays 15th Annual Global Automotive and Mobility Tech Conference November 20, 2024 8:40 AM ET Company Participants Paul Jacobson - Executive VP & CFO Conference Call Participants Dan Levy - Barclays Bank Dan Levy Great. Thank you. As we continue the Barclays Global Auto Conference, very pleased to have with us General Motors and Paul Jacobson, the company's CFO; as well as Ashish Kohli, who leads IR efforts. GM is coming on the heels of a really successful Capital Markets ...

Cisco Systems, Inc. (NASDAQ:CSCO) RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference November 20, 2024 11:20 AM ET Company Participants Scott Herren - Executive Vice President and Chief Financial Officer Conference Call Participants Matt Hedberg - RBC Matt Hedberg Please, I'll sit over here. All right. I am, oh yes, I was looking forward to this conversation for a lot of reasons. Scott and I go way -- in the way, way back -- and that's what I love about this business as ...

Novavax, Inc. (NASDAQ:NVAX) Jefferies London Healthcare Results Conference November 20, 2024 6:00 AM ET Company Participants Jim Kelly - Executive Vice President, Chief Financial Officer and Treasurer Ruxandra Draghia - Head of R&D Conference Call Participants Roger Song - Jefferies Roger Song Alright. Okay. So, sorry for the couple minutes late, but it's my pleasure. My name is Roger Song. I'm one of the senior analysts who covers mid-cap biotech in the US, and then my pleasure to introduce our next compan ...

18 November 2024 | 5:01AM GMT Peter Oppenheimer +44(20)7552-5782 | peter.oppenheimer@gs.com Goldman Sachs International Guillaume Jaisson +44(20)7552-3000 | guillaume.jaisson@gs.com Goldman Sachs International Sharon Bell +44(20)7552-1341 | sharon.bell@gs.com Goldman Sachs International Lilia Peytavin +33(1)4212-1716 | lilia.peytavin@gs.com Goldman Sachs Bank Europe SE - Paris Branch 2131d4eaf4cb4d50b1d51c8af07b64b4 The Year of the Alpha Bet Explore > n We are entering a benign part of the cycle; interest r ...

2025 OUTLOOK TIME TO DELIVER ● BARCLAYS | Private Bank Foreword 3 2025: time to deliver 4 Can the US stay in top gear? 5 Eurozone: a mild recovery? 7 Is China having its 'big bazooka' moment? 9 UK: a new paradigm? 11 A time for selectivity and quality amid shifting tides 13 Adapting to the yield cycle 18 Is AI (b)reaching its limits? 22 Material E, S and G factors in 2025 27 Is 2025 the time to decarbonise your portfolio or the planet? 33 Making sense of things 37 Multi-asset portfolio allocation 40 Key dat ...